Pricing of Offering of Inveresk Research Group, Inc. Common Stock
April 01 2004 - 10:25AM
PR Newswire (US)
Pricing of Offering of Inveresk Research Group, Inc. Common Stock
CARY, N.C., April 1 /PRNewswire-FirstCall/ -- Inveresk Research
Group, Inc. announced today that its principal stockholder
yesterday agreed to sell 5,000,000 shares of Inveresk Research
common stock at an initial price to the public of $26.75 per share.
The offering is comprised entirely of shares being offered by such
principal stockholder. The underwriter for the offering is Goldman,
Sachs & Co. This press release does not constitute an offer of
the securities described herein. A registration statement relating
to the securities has been previously declared effective by the
Securities and Exchange Commission. The offering is being made
solely by means of aprospectus supplement and the accompanying
prospectus, copies of which may be obtained from Goldman Sachs
& Co., 85 Broad Street, New York, NY 10004, Attention:
Prospectus Department. Inveresk is a leading provider of drug
development services to companies in the pharmaceutical and
biotechnology industries. The company is based in Cary, North
Carolina with facilities in Edinburgh, Scotland and Montreal,
Canada. DATASOURCE: Inveresk Research Group, Inc. CONTACT: Matt
Dallas of Financial Dynamics, +1-212-850-5627, , for Inveresk
Research Group, Inc.
Copyright
Inveresk (NASDAQ:IRGI)
Historical Stock Chart
From May 2024 to Jun 2024
Inveresk (NASDAQ:IRGI)
Historical Stock Chart
From Jun 2023 to Jun 2024